Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | STAT1 | P42224 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29360201 | 1.00 | STAT3 (0.34) | STAT3STAT1 | |
| SCHEMBL6007192 | 0.85 | STAT3 (0.36) | STAT3STAT1 | |
| SCHEMBL28423406 | 0.85 | STAT3 (0.35) | STAT3STAT1 | |
| Hydrochloric Acid SCHEMBL28420825 | 0.85 | STAT3 (0.33) | STAT3STAT1 | |
| Hydrochloric Acid SCHEMBL5150597 | 0.84 | STAT3 (0.32) | STAT3STAT1 | |
| SCHEMBL5139609 | 0.84 | STAT3 (0.36) | STAT3STAT1 | |
| SCHEMBL29469529 | 0.84 | STAT3 (0.36) | STAT3STAT1 | |
| SCHEMBL3803641 | 0.82 | STAT3 (0.51) | STAT3STAT1 | |
| SCHEMBL6007193 | 0.81 | STAT3 (0.49) | STAT3STAT1 | |
| SCHEMBL473160 | 0.73 | STAT3 (0.52) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | EQUINE PODIATRY SOLUTIONS LLC (US) | 2023-10-05 | — | — | US | claimed |
| US-20220023450-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-01-27 | — | — | US | claimed |
| EP-3849515-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | Memorial Sloan Kettering Cancer Center (US) | 2021-07-21 | — | — | EP | claimed |
| US-20210213003-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | Equine Podiatry Solutions, LLC. | 2021-07-15 | — | — | US | claimed |
| WO-2020055929-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2020-03-19 | — | — | WO | claimed |
| US-20050113427-A1 | Use of peroxynirite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence | ARGINOX, INC. (US) | 2005-05-26 | — | — | US | claimed |
| US-20030086916-A1 | Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence | ARGINOX, INC. | 2003-05-08 | — | — | US | claimed |
| US-11813254-B2 | Compositions and methods for reducing laminitis of an animal hoof | Equine Podiatry Solutions, LLC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | EQUINE PODIATRY SOLUTIONS LLC (US) | 2023-10-05 | — | — | US | disclosed |
| WO-2023069892-A1 | CONDITIONALLY ACTIVE PROTEINS FOR NEURODEGENERATIVE DISEASES | SHORT JAY M (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20230087020-A1 | COMPOSITION FOR EXTENDING VIABLE PRESERVATION AND SHELF-LIFE OF ORGANS AND TISSUES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-03-23 | — | — | US | disclosed |
| US-20220023450-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-01-27 | — | — | US | disclosed |
| WO-2021183653-A1 | COMPOSITIONS FOR EXTENDING VIABLE PRESERVATION AND SHELF-LIFE OF ORGANS AND TISSUES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-09-16 | — | — | WO | disclosed |
| US-20040142906-A1 | Conpositions and method to prevent and treat brain and spinal cord injuries | WANG YANMING (US) | 2004-07-22 | — | — | US | disclosed |
| US-20040138125-A1 | Composition and method to prevent and treat brain and spinal cord injuries | WANG YANMING (US) | 2004-07-15 | — | — | US | disclosed |
| US-6683066-B2 | Composition and treatment method for brain and spinal cord injuries | WANG YANMING (US) | 2004-01-27 | — | — | US | disclosed |
| CN-1450066-A | Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant | GONG XIANCHANG (CN) | 2003-10-22 | — | — | CN | disclosed |
| US-20030086916-A1 | Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence | ARGINOX, INC. | 2003-05-08 | — | — | US | disclosed |
| WO-2003026565-A2 | COMPOSITION AND TREATMENT METHOD FOR BRAIN AND SPINAL CORD INJURIES | WANG YANMING (US) | 2003-04-03 | — | — | WO | disclosed |
| US-20030059476-A1 | Composition and treatment method for brain and spinal cord injuries | WANG YANMING (US) | 2003-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210213003-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | COX15, HMOX2, HMOX1 | STAT3 2646/4885STAT1 2307/4885 |
| US-20220023450-A1 | BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE | KIT, LIPA, CTSA | STAT3 2324/4885STAT1 3480/4885 |
| US-11813254-B2 | Compositions and methods for reducing laminitis of an animal hoof | COX15, HMOX2, HMOX1 | STAT3 2646/4885STAT1 2307/4885 |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | COX15, HMOX2, HMOX1 | STAT3 2646/4885STAT1 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.